Colorado Health Center COVID-19 Survey Summary Report

Latest data from September 24, 2021

Number of Health Center respondents = 16 (84% of all Health Centers)

Data represents information provided by health centers from a single, specified reporting date. Summary information across report dates is not comparable due to differences in which health centers responded for a given report date.

Patients Tested

Metrics Value
Patients Tested for COVID-19, Virus Detection (PCR, antigen)1 8,754
Racial and/or Ethnic Minority Patients Tested for COVID-19, Virus Detection (PCR, antigen) 68.93%
Patients Tested Positive for COVID-19, Virus Detection (PCR, antigen)1 804
Racial and/or Ethnic Minority Patients Tested Positive for COVID-19, Virus Detection (PCR, antigen) 68.20%

Patients by Race and Ethnicity

Race/Ethnicity Patients Tested, Virus Detection (PCR, antigen)2 Patients Tested Positive, Virus Detection (PCR, antigen)2
White, Non-Hispanic/Latino Patients 27.19% 27.49%
White, Hispanic/Latino Patients 33.84% 34.45%
Black/African American, Non-Hispanic/Latino Patients 8.14% 7.21%
Black/African American, Hispanic/Latino Patients 0.47% 0.00%
Asian Patients3 1.82% 1.00%
American Indian/Alaska Native Patients3 1.28% 1.24%
Native Hawaiian/Other Pacific Islander Patients3 0.33% 0.87%
Patients with More than one race3 1.21% 2.24%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 13.22% 11.94%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 4.18% 3.73%
Unreported/Refused to Report Race and Ethnicity 8.33% 9.83%

Patients Vaccinated

Metrics Value
COVID-19 Immunization Series Initiated 3,013
Racial and/or Ethnic Minority Patients Who Initiated COVID-19 Immunization 79.02%
COVID-19 Immunization Series Completed 3,503
Racial and/or Ethnic Minority Patients Who Completed COVID-19 Immunization 77.59%
COVID-19 Immunization Series Additional 1,130
Racial and/or Ethnic Minority Patients Who Received an Additional Dose of COVID-19 Vaccine 47.89%

Vaccinations by Race and Ethnicity

Race/Ethnicity Patient COVID-19 Immunization Series Initiated2 Patient COVID-19 Immunization Series Completed2 Patient COVID-19 Immunization Series Additional2
White, Non-Hispanic/Latino Patients 18.62% 19.81% 45.93%
White, Hispanic/Latino Patients 40.42% 39.97% 22.30%
Black/African American, Non-Hispanic/Latino Patients 9.59% 7.96% 6.81%
Black/African American, Hispanic/Latino Patients 0.50% 0.29% 0.18%
Asian Patients3 1.56% 1.80% 3.19%
American Indian/Alaska Native Patients3 1.00% 1.08% 0.71%
Native Hawaiian/Other Pacific Islander Patients3 0.50% 0.29% 0.44%
Patients with More than one race3 0.86% 1.00% 0.44%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 15.70% 16.21% 8.14%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 1.79% 1.74% 0.53%
Unreported/Refused to Report Race and Ethnicity 9.46% 9.85% 11.33%

Testing Logistics

Average Turnaround Time for COVID-19 Test Results, Virus Detection (PCR, antigen)

Metrics Value
Less Than 1 Hour 31.25%
1 to 24 Hours 37.50%
More Than 24 Hours 31.25%
N/A 0.00%

Vaccine Logistics

Challenges in Deploying the COVID Vaccine

Metrics Value
Financial reimbursement for costs associated with vaccine administration 18.75%
Staffing to administer the vaccine 37.50%
Vaccine confidence 50.00%
Vaccine storage capacity 0.00%
Vaccine supply 0.00%
Other 0.00%
None 25.00%

Operations and Staff

Metrics Value
Health Center Weekly Visits Compared to Pre-COVID 19 Weekly Visits 88.12%
Average Percent of Health Center Visits Conducted Virtually 12.19%

Mobile Vans, Pop-Up Clinics, and School-Based Sites

Metrics Value
Percent of Health Centers Hosting Mobile Vans, Pop-Up, and/or School-Based Clinics 37.50%
Number of Mobile Van Sites 20
Number of Pop-up Clinics 17
Number of School-Based Vaccination Sites 1

Monoclonal Antibody Therapy

Methods in Providing Access to Monoclonal Antibody Therapy

Metrics Value
Direct provision of monoclonal antibody therapies 6.25%
Refer patients to another organization that provides monoclonal antibody therapies 43.75%
None 50.00%

Challenges in Providing Access to Monoclonal Antibody Therapy

Metrics Value
Access to therapeutics 6.25%
Patient awareness/education 12.50%
Staffing capacity 25.00%
Therapy administration/onsite logistics 6.25%
Other 12.50%
None 50.00%

1 The reported number of patients tested do not represent the same patients included in the reported number of patients tested positive due to a lag between the date the specimen is collected and the availability of test results. Positivity rates cannot be inferred by dividing patients tested positive by patients tested for this reason.

2 Percentages may not add to 100% due to rounding to the hundredths.

3 Includes Hispanic/Latino and Non-Hispanic/Latino.

Date Last Reviewed:  October 2021